Possession, use, and transfer of select agents and toxins; biennial review. Final rule.
about
Modeling human influenza infection in the laboratoryOn botulinum neurotoxin variabilityComparative review of Francisella tularensis and Francisella novicidaGlyburide reduces bacterial dissemination in a mouse model of melioidosisStructural insights into WcbI, a novel polysaccharide-biosynthesis enzymeHuman melioidosis reported by ProMEDBioterrorism and the Role of the Clinical Microbiology LaboratoryAntigen Production in Plant to Tackle Infectious Diseases Flare Up: The Case of SARS.Variation in Tularemia Clinical Manifestations-Arkansas, 2009-2013.Challenges and Practices in Building and Implementing Biosafety and Biosecurity Programs to Enable Basic and Translational Research with Select Agents.Glycosylation of a Capsule-Like Complex (CLC) by Francisella novicida Is Required for Virulence and Partial Protective Immunity in Mice.EmrA1 membrane fusion protein of Francisella tularensis LVS is required for resistance to oxidative stress, intramacrophage survival and virulence in mice.International Society for the Advancement of Cytometry cell sorter biosafety standards.Proteomic analysis of the Burkholderia pseudomallei type II secretome reveals hydrolytic enzymes, novel proteins, and the deubiquitinase TssMFrancisella tularensis bacteria associated with feline tularemia in the United States.Identification of a live attenuated vaccine candidate for tularemia prophylaxisClinical, environmental, and serologic surveillance studies of melioidosis in Gabon, 2012-2013Francisella tularensis Subtype A.II Genomic Plasticity in Comparison with Subtype A.I.Differential Toll-Like Receptor-Signalling of Burkholderia pseudomallei Lipopolysaccharide in Murine and Human Models.Characterization of New Virulence Factors Involved in the Intracellular Growth and Survival of Burkholderia pseudomallei.Review of Restricted Experiment Requests, Division of Select Agents and Toxins, Centers for Disease Control and Prevention, 2006-2013.Potentiation of the Fosmidomycin analogue FR 900098 with substituted 2-oxazolines against Francisella novicidaIntramuscular Immunization of Mice with a Live-Attenuated Triple Mutant of Yersinia pestis CO92 Induces Robust Humoral and Cell-Mediated Immunity To Completely Protect Animals against Pneumonic Plague.Neutrophil extracellular traps in the host defense against sepsis induced by Burkholderia pseudomallei (melioidosis)A Novel Inhibitor Prevents the Peripheral Neuroparalysis of Botulinum Neurotoxins.Effective Disinfectants for Coccidioides immitis and C. posadasiiDiffering effects of interleukin-10 on cutaneous and pulmonary Francisella tularensis live vaccine strain infection.Implementation of a personnel reliability program as a facilitator of biosafety and biosecurity culture in BSL-3 and BSL-4 laboratoriesIncreased susceptibility of IgA-deficient mice to pulmonary Francisella tularensis live vaccine strain infectionSensitive Detection of Francisella tularensis Directly from Whole Blood by Use of the GeneXpert System.Melioidosis: molecular aspects of pathogenesis.Inhibition of arenavirus by A3, a pyrimidine biosynthesis inhibitor.Molecular investigation of tularemia outbreaks, Spain, 1997-2008.Differences in Inflammation Patterns Induced by African and Asian Burkholderia pseudomallei Isolates in Mice.Towards Development of Improved Serodiagnostics for Tularemia by Use of Francisella tularensis Proteome MicroarraysThe contribution of the glycine cleavage system to the pathogenesis of Francisella tularensis.Characterization of Inner and Outer Membrane Proteins from Francisella tularensis Strains LVS and Schu S4 and Identification of Potential Subunit Vaccine Candidates.Tularemia - United States, 2001-2010.The first non Clostridial botulinum-like toxin cleaves VAMP within the juxtamembrane domain.Structural characterisation of the capsular polysaccharide expressed by Burkholderia thailandensis strain E555:: wbiI (pKnock-KmR) and assessment of the significance of the 2-O-acetyl group in immune protection.
P2860
Q26781842-176E66E9-59D5-4D73-816C-0B01C1093508Q27007548-2E7218FD-22E7-4220-9A64-500F6D5FCCC6Q27027396-475E2316-20A5-491F-99BD-A52A76A4A18FQ27305020-E15EC775-86DF-4728-99F1-639595382156Q27684860-FC6830A7-EE3A-4E00-8E14-361D9B48DDDFQ28261954-70F3C6B1-74B1-4FFA-B230-D69C27FB4D02Q28388247-CFF23D7E-3FF8-4C9D-85AD-038B820D810BQ30384772-C217CFBB-E039-4664-84C8-2C325D09BD99Q33629549-F96F53D5-8725-4D80-944A-1A1C9B670039Q33699916-FEC9E9A3-AFBF-46C3-B3FA-4347E2E1A176Q33736711-A15D1E77-A3BE-4BF1-85B5-B8C24DEF3753Q33897837-D76FF3C5-9D61-43F4-BAA6-D2218002ACEFQ33981457-DF146E6D-1FD9-48D2-955D-2ECA9BA67062Q34059012-0595BCE8-1CCC-405C-9FA3-603AE6A6CA10Q34641336-6C73959E-3F17-4955-A52A-357466889B1CQ34684536-4715A875-A93E-4300-AC39-B753DDF8B000Q34843970-D2D5985A-E5E0-4B2B-8EBE-EB6B50521B00Q35547640-FEAD6E68-CA04-4E20-8E7B-F4B58C9478C4Q35874189-65E61432-6ED9-4E5E-9D5D-CE000C789CEBQ35880149-7886D25E-4BA0-4343-80BE-3B4DEFDF3257Q36092119-5FF3A9EC-C872-4E53-B8FA-BDC35FDF3B52Q36268462-B5FE48BA-4DC8-49E4-AE88-D27A28E62CBEQ36316792-B01BB9A3-C677-4D3B-AA97-C701B044278DQ36369202-AC6F3D28-418D-4048-9E2B-26F0AD2B2FD0Q36376074-D2659212-7487-4F55-9F77-9BA105C11F16Q36598594-D33766E8-4524-40A6-8C3E-DECF0A440E23Q36911513-BD005601-3B61-4ECC-9D9C-9ED417AFFFADQ36945787-87016AAA-6892-4109-9D70-B8FF4420B2D7Q37123754-9BA8092E-4B22-4982-BA98-87C85BAFAA1CQ37581895-144E54CF-5E34-4449-B5A1-BCAB9002072DQ38259874-8F450118-3C4D-4543-B0DD-25F403356C95Q39066377-C7BAF529-FC0E-484A-8845-E904087E0D5DQ39328747-E8DD33D4-9458-408B-963A-4979FF0AD4EDQ39583629-A78E35E0-0DAC-4633-B1A2-2FAB8D5D4ABBQ40705741-B2EE30DB-8D37-4842-B2EE-6556519AA4AEQ41869119-48B1B7B4-97D7-4BE5-A0D4-8670C0721967Q41987534-78457C39-21FE-438B-A95D-27CD35A8865EQ42239055-106DB353-07C8-4357-BE99-4635D9909B13Q42408273-C5E8E487-61C6-45BF-BB49-B978BF5EA99FQ45731787-836EC1A7-5715-4A7B-99DE-46696185DD8D
P2860
Possession, use, and transfer of select agents and toxins; biennial review. Final rule.
description
2012 nî lūn-bûn
@nan
2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Possession, use, and transfer of select agents and toxins; biennial review. Final rule.
@ast
Possession, use, and transfer of select agents and toxins; biennial review. Final rule.
@en
type
label
Possession, use, and transfer of select agents and toxins; biennial review. Final rule.
@ast
Possession, use, and transfer of select agents and toxins; biennial review. Final rule.
@en
prefLabel
Possession, use, and transfer of select agents and toxins; biennial review. Final rule.
@ast
Possession, use, and transfer of select agents and toxins; biennial review. Final rule.
@en
P1433
P1476
Possession, use, and transfer of select agents and toxins; biennial review. Final rule.
@en
P2093
Centers for Disease Control an ...... ealth and Human Services (HHS)
P304
61083-61115
P577
2012-10-01T00:00:00Z